A detailed history of Vision Financial Markets LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vision Financial Markets LLC holds 3,000 shares of ADMA stock, worth $50,610. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,000
Holding current value
$50,610
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$15.62 - $22.62 $46,860 - $67,860
3,000 New
3,000 $51.5 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.31B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Vision Financial Markets LLC Portfolio

Follow Vision Financial Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vision Financial Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vision Financial Markets LLC with notifications on news.